Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.3K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.3K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

7.8K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.8K
The Ras Gene02:38

The Ras Gene

6.4K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.4K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

4.2K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
4.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Herpes Zoster: Risk Factors for Occurrence, Complications, and Recurrence with a Focus on Immunocompromised Patients.

Diseases (Basel, Switzerland)·2025
Same author

New Insights on Respiratory Syncytial Virus Prevention.

Vaccines·2023
Same author

Rotavirus Vaccination of Premature Newborns in the NICU: Evaluation of Vaccination Rates and Safety Based on a Single-Centre Study.

Vaccines·2023
Same author

Trained Immunity, BCG and SARS-CoV-2 General Outline and Possible Management in COVID-19.

International journal of molecular sciences·2023
Same author

A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled Phase III Clinical Trial Evaluating the Impact of BCG Re-Vaccination on the Incidence and Severity of SARS-CoV-2 Infections among Symptomatic Healthcare Professionals during the COVID-19 Pandemic in Poland-Evaluation of Antibody Concentrations.

Vaccines·2023
Same author

Nanoemulsions as Gene Delivery in Mucopolysaccharidosis Type I-A Mini-Review.

International journal of molecular sciences·2022

Related Experiment Video

Updated: Sep 5, 2025

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
09:16

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Published on: September 1, 2019

7.7K

RNF6 as an Oncogene and Potential Therapeutic Target-A Review.

Paweł Zapolnik1, Antoni Pyrkosz2

  • 1Students' Scientific Association of Clinical Genetics, Department of Clinical Genetics, Medical College, University of Rzeszów, Al. Kopisto 2a, 35-959 Rzeszów, Poland.

Biotech (Basel (Switzerland))
|July 13, 2022
PubMed
Summary

Ring Finger Protein 6 (RNF6) acts as an oncogene in human cancers, promoting tumor growth through various signaling pathways. Inhibiting RNF6 shows promise for cancer therapy, though further research is needed.

Keywords:
RNF6molecular targeted therapyneoplasmsoncogenesreview

More Related Videos

Author Spotlight: RNA FISH for Locating lncRNA-SNHG6 in Osteosarcoma Cells
05:27

Author Spotlight: RNA FISH for Locating lncRNA-SNHG6 in Osteosarcoma Cells

Published on: June 16, 2023

1.7K
Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

8.4K

Related Experiment Videos

Last Updated: Sep 5, 2025

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
09:16

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Published on: September 1, 2019

7.7K
Author Spotlight: RNA FISH for Locating lncRNA-SNHG6 in Osteosarcoma Cells
05:27

Author Spotlight: RNA FISH for Locating lncRNA-SNHG6 in Osteosarcoma Cells

Published on: June 16, 2023

1.7K
Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

8.4K

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Ring Finger Protein 6 (RNF6) is a ubiquitin ligase implicated in human cancer development.
  • Initially considered a tumor suppressor, RNF6 is now recognized for its oncogenic functions.
  • RNF6 participates in critical signaling pathways such as SHP1/STAT3, AKT/mTOR, Wnt/β-catenin, and ERα/Bcl-xL.

Purpose of the Study:

  • To investigate the dual role of RNF6 in cancer, moving from a tumor suppressor to an oncogene.
  • To explore RNF6 as a potential prognostic factor and therapeutic target in human cancers.
  • To evaluate the efficacy of RNF6 inhibitors in preclinical models.

Main Methods:

  • Analysis of statistical data from cell lines and animal models.
  • Investigation of RNF6's involvement in key cancer-related signaling pathways.
  • Testing the effects of RNF6 inhibitors, including total saponins from Paris forrestii (TSPf), ellagic acid, and microRNAs, on tumor cell proliferation.

Main Results:

  • Evidence suggests RNF6 functions as an oncogene, driving tumor cell proliferation.
  • Inhibitors targeting RNF6 and its associated pathways demonstrate effectiveness in reducing tumor cell growth.
  • RNF6 is identified as a potential prognostic marker and therapeutic target.

Conclusions:

  • RNF6 plays a significant role as an oncogene in human cancers.
  • Inhibiting RNF6 presents a promising therapeutic strategy.
  • Further research is essential to fully elucidate RNF6's function and validate inhibitor safety and efficacy.